Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study
McInnes, Iain B, Mease, Philip J, Schett, Georg, Kirkham, Bruce, Strand, Vibeke, Williams, Nicole, Fox, Todd, Pricop, Luminita, Jugl, Steffen M, Gandhi, Kunal K
Published in Arthritis research & therapy (07.06.2018)
Published in Arthritis research & therapy (07.06.2018)
Get full text
Journal Article
Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study
Conaghan, P G, Alten, Rieke, Deodhar, Atul, Sullivan, Emma, Blackburn, Stuart, Tian, Haijun, Gandhi, Kunal, Jugl, Steffen M, Strand, Vibeke
Published in Rheumatic & musculoskeletal diseases open (01.06.2020)
Published in Rheumatic & musculoskeletal diseases open (01.06.2020)
Get full text
Journal Article
Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison
Mease, Philip, Choy, Ernest, Nash, Peter, Kalyvas, Chrysostomos, Hunger, Matthias, Pricop, Luminita, Gandhi, Kunal K, Jugl, Steffen M, Thom, Howard
Published in European journal of rheumatology (01.07.2019)
Published in European journal of rheumatology (01.07.2019)
Get full text
Journal Article
Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2‐Year Results From a Multicenter, Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase III Study
Coates, Laura C., Mease, Philip J., Gossec, Laure, Kirkham, Bruce, Sherif, Bintu, Gaillez, Corine, Mpofu, Shephard, Jugl, Steffen M., Karyekar, Chetan, Gandhi, Kunal K.
Published in Arthritis care & research (2010) (01.10.2018)
Published in Arthritis care & research (2010) (01.10.2018)
Get full text
Journal Article
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study
Coates, Laura C., Nash, Peter, Kvien, Tore K., Gossec, Laure, Mease, Philip J., Rasouliyan, Lawrence, Pricop, Luminita, Jugl, Steffen M., Gandhi, Kunal K., Gaillez, Corine, Smolen, Josef S.
Published in Seminars in arthritis and rheumatism (01.08.2020)
Published in Seminars in arthritis and rheumatism (01.08.2020)
Get full text
Journal Article
Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis
Krüger, Klaus, von Hinüber, Ulrich, Meier, Florian, Tian, Haijun, Böhm, Katharina, Jugl, Steffen M., Borchert, Kathrin, Meise, Dominic, König, Christine, Braun, Sebastian
Published in Rheumatology international (01.11.2018)
Published in Rheumatology international (01.11.2018)
Get full text
Journal Article
Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE 2 study
Deodhar, Atul, Conaghan, Philip G, Kvien, Tore K, Strand, Vibeke, Sherif, Bintu, Porter, Brian, Jugl, Steffen M, Gandhi, Kunal K
Published in Clinical and experimental rheumatology (01.03.2019)
Get full text
Published in Clinical and experimental rheumatology (01.03.2019)
Journal Article
Secukinumab for psoriatic arthritis: comparative effectiveness versus licensed biologics/apremilast: a network meta-analysis
McInnes, Iain B, Nash, Peter, Ritchlin, Christopher, Choy, Ernest H, Kanters, Steve, Thom, Howard, Gandhi, Kunal, Pricop, Luminita, Jugl, Steffen M
Published in Journal of comparative effectiveness research (01.11.2018)
Published in Journal of comparative effectiveness research (01.11.2018)
Get full text
Journal Article
Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
Nash, Peter, McInnes, Iain B., Mease, Philip J., Thom, Howard, Hunger, Matthias, Karabis, Andreas, Gandhi, Kunal, Mpofu, Shephard, Jugl, Steffen M.
Published in Rheumatology and therapy. (01.06.2018)
Published in Rheumatology and therapy. (01.06.2018)
Get full text
Journal Article
Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective
Goeree, Ron, Chiva-Razavi, Sima, Gunda, Praveen, Graham, Christopher N, Miles, LaStella, Nikoglou, Efthalia, Jugl, Steffen M, Gladman, Dafna D
Published in Journal of medical economics (01.02.2018)
Published in Journal of medical economics (01.02.2018)
Get more information
Journal Article
Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison
Maksymowych, Walter P, Strand, Vibeke, Nash, Peter, Yazici, Yusuf, Thom, Howard, Hunger, Matthias, Kalyvas, Chrysostomos, Gandhi, Kunal K, Porter, Brian, Jugl, Steffen M
Published in European journal of rheumatology (01.12.2018)
Published in European journal of rheumatology (01.12.2018)
Get full text
Journal Article
Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
Colombo, Giorgio L, Di Matteo, Sergio, Martinotti, Chiara, Jugl, Steffen M, Gunda, Praveen, Naclerio, Mariantonietta, Bruno, Giacomo M
Published in ClinicoEconomics and outcomes research (01.01.2018)
Published in ClinicoEconomics and outcomes research (01.01.2018)
Get full text
Journal Article
Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
Nash, Peter, McInnes, Iain B., Mease, Philip J., Thom, Howard, Hunger, Matthias, Karabis, Andreas, Gandhi, Kunal, Mpofu, Shephard, Jugl, Steffen M.
Published in Rheumatology and therapy. (01.12.2018)
Published in Rheumatology and therapy. (01.12.2018)
Get full text
Journal Article